COVID-19 infection and rheumatoid arthritis: Faraway, so close!

EG Favalli, F Ingegnoli, O De Lucia, G Cincinelli… - Autoimmunity …, 2020 - Elsevier
The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has
quickly become a global health emergency. Given the lack of specific anti-viral therapies, the …

Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis

A Picca, HJ Coelho-Junior, R Calvani, E Marzetti… - Ageing research …, 2022 - Elsevier
Background Physical frailty and sarcopenia show extensive clinical similarities. Whether
biomarkers exist that are shared by the two conditions is presently unclear. Methods We …

Dexamethasone for the treatment of coronavirus disease (COVID-19): a review

MH Ahmed, A Hassan - SN comprehensive clinical medicine, 2020 - Springer
Abstract The World Health Organization (WHO) declared COVID-19 (novel coronavirus) as a
global pandemic in the middle of March 2020, after the disease spread to more than 150 …

Inflammatory and vascular biomarkers in post‐COVID‐19 syndrome: A systematic review and meta‐analysis of over 20 biomarkers

SJ Yong, A Halim, M Halim, S Liu… - Reviews in medical …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 may inflict a post‐viral condition known as
post‐COVID‐19 syndrome (PCS) or long‐COVID. Studies measuring levels of inflammatory …

Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches

A Kato, AT Peters, WW Stevens, RP Schleimer… - Allergy, 2022 - Wiley Online Library
Chronic rhinosinusitis (CRS) is a common clinical syndrome that produces significant
morbidity and costs to our health system. The study of CRS has progressed from an era …

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

C Perricone, P Triggianese, E Bartoloni, G Cafaro… - Journal of …, 2020 - Elsevier
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection has posed the world at a pandemic risk. Coronavirus-19 disease (COVID-19) is an …

New insights into the cell-and tissue-specificity of glucocorticoid actions

L Quatrini, S Ugolini - Cellular & molecular immunology, 2021 - nature.com
Glucocorticoids (GCs) are endogenous hormones that are crucial for the homeostasis of the
organism and adaptation to the external environment. Because of their anti-inflammatory …

Inflammatory bowel disease treatments and predictive biomarkers of therapeutic response

DA Elhag, M Kumar, M Saadaoui, AK Akobeng… - International journal of …, 2022 - mdpi.com
Inflammatory bowel disease (IBD) is a chronic immune-mediated inflammation of the
gastrointestinal tract with a highly heterogeneous presentation. It has a relapsing and …

Flattening the COVID-19 curve with natural killer cell based immunotherapies

M Market, L Angka, AB Martel, D Bastin… - Frontiers in …, 2020 - frontiersin.org
Natural Killer (NK) cells are innate immune responders critical for viral clearance and
immunomodulation. Despite their vital role in viral infection, the contribution of NK cells in …

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …